| Hamdard Health Alliance | |
|
228 E Lake St Addison IL 60101-2889 | |
| (630) 835-1430 | |
| Not Available |
| Full Name | Hamdard Health Alliance |
|---|---|
| Speciality | Clinic/Center |
| Location | 228 E Lake St, Addison, Illinois |
| Authorized Official Name and Position | Shawn Bailey (FINANCE ADMINISTRATION MANAGER) |
| Authorized Official Contact | 6308351430 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Hamdard Health Alliance 228 E Lake St Addison IL 60101-2889 Ph: (630) 835-1430 | Hamdard Health Alliance 228 E Lake St Addison IL 60101-2889 Ph: (630) 835-1430 |
| NPI Number | 1609875053 |
|---|---|
| Provider Enumeration Date | 07/19/2005 |
| Last Update Date | 12/26/2023 |
| Medicare PECOS PAC ID | 4880680289 |
|---|---|
| Medicare Enrollment ID | O20040421001679 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609875053 | NPI | - | NPPES |
| 781811 | Other | IL | PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (* (Not Available)) | Primary |
| Provider Name | Sarada Alla |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1770611964 PECOS PAC ID: 2567364458 Enrollment ID: I20040122000108 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Muhammed Saudye |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1013918804 PECOS PAC ID: 1658267372 Enrollment ID: I20040227000404 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Anjum N Khaja |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1790876837 PECOS PAC ID: 4981592813 Enrollment ID: I20040310000844 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Shona Mairi Hillman |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1275570699 PECOS PAC ID: 6204829443 Enrollment ID: I20040405001202 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Zarina Merchant |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1154376572 PECOS PAC ID: 1052392081 Enrollment ID: I20040526000781 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Grettel C Donahue |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1477605913 PECOS PAC ID: 9537139654 Enrollment ID: I20040727001371 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Ilah Heller-bair |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1336206150 PECOS PAC ID: 9335128180 Enrollment ID: I20050329000037 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Alvia Sabahat |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1699707851 PECOS PAC ID: 2365480860 Enrollment ID: I20050425000175 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Ghazala Fayyaz |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1649223595 PECOS PAC ID: 7012945488 Enrollment ID: I20050728000188 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Zella Moore |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1285747816 PECOS PAC ID: 8123025673 Enrollment ID: I20061026000243 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Muhammed Imran |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1215962071 PECOS PAC ID: 1456454172 Enrollment ID: I20070316000233 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Jabeen Aqueel |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1689883225 PECOS PAC ID: 4587764873 Enrollment ID: I20070716000605 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Saad Alvi |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1194983981 PECOS PAC ID: 0941374805 Enrollment ID: I20080811000556 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Mohammed M Alam |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1366524050 PECOS PAC ID: 2365500329 Enrollment ID: I20081020000293 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Valentin Berman |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1750428967 PECOS PAC ID: 8022028422 Enrollment ID: I20081213000152 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Reginald Nnamdi Okagbue |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1235309352 PECOS PAC ID: 0244426914 Enrollment ID: I20101119000572 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Dragoslav Gvozdjan |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1003006701 PECOS PAC ID: 4688854995 Enrollment ID: I20110203000530 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Irma Teresa Esposito |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1184863672 PECOS PAC ID: 0840453593 Enrollment ID: I20120517000088 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Mohammad Hamid |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1679908743 PECOS PAC ID: 8123014529 Enrollment ID: I20131025000025 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Shuja M Uddin |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1871832790 PECOS PAC ID: 0840425831 Enrollment ID: I20131029000596 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Erica E Taylor |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1932364551 PECOS PAC ID: 2567695968 Enrollment ID: I20140509001997 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Neeli Sudin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1477586980 PECOS PAC ID: 5496768939 Enrollment ID: I20140808001652 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Parveen Azam |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1477639078 PECOS PAC ID: 9537487129 Enrollment ID: I20150410001000 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Shanti P Subbarao |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1487910295 PECOS PAC ID: 9638484850 Enrollment ID: I20151130001274 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Jennifer L Dicostanzo |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1487072070 PECOS PAC ID: 7315237435 Enrollment ID: I20160602000263 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Anna Matyja |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1255789285 PECOS PAC ID: 6800177213 Enrollment ID: I20161223000192 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Sarah M Khan |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1922446186 PECOS PAC ID: 1052617362 Enrollment ID: I20170425002378 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Steffanie Meeks |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1205386174 PECOS PAC ID: 6204113335 Enrollment ID: I20170427001387 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Renee Kim |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1770975831 PECOS PAC ID: 6608142724 Enrollment ID: I20171017003489 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Uzma T Shamsi |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1003334418 PECOS PAC ID: 1254690456 Enrollment ID: I20180116001631 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Nadijda Bassil |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1730445743 PECOS PAC ID: 1254648694 Enrollment ID: I20181001000922 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Dana Elsherif |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1013270024 PECOS PAC ID: 5698081321 Enrollment ID: I20190116000214 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Sana Waseem |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1366805483 PECOS PAC ID: 5799071221 Enrollment ID: I20190828003770 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Katherine M Johnson |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1750939476 PECOS PAC ID: 6204166671 Enrollment ID: I20190927000191 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Janet Vidales |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1013558196 PECOS PAC ID: 4587996723 Enrollment ID: I20191021003218 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Ashley N Evans |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1962056234 PECOS PAC ID: 6800220807 Enrollment ID: I20191230000180 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Damaso Allen Hodges |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1639443138 PECOS PAC ID: 6901233519 Enrollment ID: I20200220001407 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Rubina Siddiq Baig |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1659809879 PECOS PAC ID: 3577831239 Enrollment ID: I20200807001840 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Imuentiyan Oyesiku |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1467064154 PECOS PAC ID: 9335569086 Enrollment ID: I20201019000513 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Talha Baloch |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1548640535 PECOS PAC ID: 8820319114 Enrollment ID: I20210122000792 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Crystal B Daniels |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1962400556 PECOS PAC ID: 0345657219 Enrollment ID: I20210322002085 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Joan E Vargas-herzfeldt |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1326768599 PECOS PAC ID: 7517334428 Enrollment ID: I20221107001698 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Amrit K Singh |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1477274538 PECOS PAC ID: 3870960529 Enrollment ID: I20221109001179 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
| Provider Name | Trinidad Morin |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1154916310 PECOS PAC ID: 7416393772 Enrollment ID: I20240308000630 |
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
News Archive
This New Year, we can make the same tired resolutions - start exercising, eat better, stop smoking - or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.
Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.
› Verified 7 days ago
Medical Square Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 276 W Fullerton Ave, Addison, IL 60101 Phone: 630-543-5454 Fax: 630-543-5471 | |
Access Community Health Network Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1111 W Lake St, Addison, IL 60101 Phone: 773-257-6770 | |
Concentra Urgent Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 501 South Grace Street, Addison, IL 60101 Phone: 630-543-4040 Fax: 630-543-1050 | |
Ricardo Martinez, Md, Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1201 W Army Trail Blvd, Addison, IL 60101 Phone: 630-458-9200 Fax: 630-458-8460 | |
Concentra Medical Centers Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 501 S Grace St, Addison, IL 60101 Phone: 630-543-4040 Fax: 630-543-1050 | |
Bozena Scigacz Medical Office S.c. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 28 W Lake St, Suite 2, Addison, IL 60101 Phone: 630-458-0688 Fax: 630-458-0698 | |
Primary Care Associates Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 303 W Lake St, Suite 206, Addison, IL 60101 Phone: 630-543-4200 |